1. Home
  2. THH vs BNGO Comparison

THH vs BNGO Comparison

Compare THH & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TryHard Holdings Limited Ordinary Shares

THH

TryHard Holdings Limited Ordinary Shares

SELL

Current Price

$0.31

Market Cap

15.6M

Sector

N/A

ML Signal

SELL

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.15

Market Cap

12.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
THH
BNGO
Founded
2013
2003
Country
Japan
United States
Employees
116
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
12.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
THH
BNGO
Price
$0.31
$1.15
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
1.2M
140.9K
Earning Date
05-19-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.50
EPS
N/A
N/A
Revenue
N/A
$12,000,735.00
Revenue This Year
N/A
$14.99
Revenue Next Year
N/A
$34.73
P/E Ratio
$305.05
N/A
Revenue Growth
N/A
26.26
52 Week Low
$0.25
$1.06
52 Week High
$56.26
$5.50

Technical Indicators

Market Signals
Indicator
THH
BNGO
Relative Strength Index (RSI) 47.93 45.30
Support Level $0.28 $1.13
Resistance Level $0.53 $1.18
Average True Range (ATR) 0.05 0.04
MACD 0.00 0.00
Stochastic Oscillator 20.73 33.33

Price Performance

Historical Comparison
THH
BNGO

About THH TryHard Holdings Limited Ordinary Shares

Tryhard Holdings Ltd is a Japan-based lifestyle entertainment company offering services across the entertainment and hospitality sectors. Its main businesses include event curation, consultancy and management, sub-leasing of venues, and restaurant operations. The company operates through four segments, with the majority of revenue generated from consultancy and management, which provides club planning, operations, event production, entertainer bookings, and sponsorship services. The event curation segment produces both in-house and client events; the sub-leasing segment rents venues and sub-leases them to clubs; and the restaurants segment operates themed dining outlets that complement its entertainment offerings.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: